Happy Holidays and New year from the EMDB! Please be advised that the EMDB team will be operating at reduced capacity between December 15th - January 12th. With this in mind we would ask that you be prepared for longer reply times through both our helpdesk system and the OneDep deposition system. well done on a productive 2025, wishing you all the best and we will see you in 2026!
EMD-24894
Ab16 Fab in complex with SARS-CoV-2 Spike (6P)
EMD-24894
Single-particle5.5 Å
Deposition: 17/09/2021Map released: 05/10/2022
Last modified: 23/11/2022
Sample Organism:
Homo sapiens
Sample: Ab16 Fab in complex with SARS-CoV-2 Spike (6P)
Deposition Authors: Windsor IW, Hauser BM
,
Schmidt AG
Sample: Ab16 Fab in complex with SARS-CoV-2 Spike (6P)
Deposition Authors: Windsor IW, Hauser BM
,
Schmidt AG
Rationally designed immunogens enable immune focusing following SARS-CoV-2 spike imprinting.
Hauser BM
,
Sangesland M
,
St Denis KJ,
Lam EC
,
Case JB,
Windsor IW,
Feldman J
,
Caradonna TM
,
Kannegieter T,
Diamond MS,
Balazs AB
,
Lingwood D,
Schmidt AG
(2022) Cell Rep , 38 , 110561 - 110561
,
Sangesland M
,
St Denis KJ,
Lam EC
,
Case JB,
Windsor IW,
Feldman J
,
Caradonna TM
,
Kannegieter T,
Diamond MS,
Balazs AB
,
Lingwood D,
Schmidt AG
(2022) Cell Rep , 38 , 110561 - 110561
Grant Support:
- National Institutes of Health/National Institute Of Allergy and Infectious Diseases (NIH/NIAID): R01 AI146779 (United States)
- Other government: Massachusetts Consortium on Pathogenesis Readiness (MassCPR) (United States)
- National Institutes of Health/National Institute of General Medical Sciences (NIH/NIGMS): T32 GM007753 (United States)
